digplanet beta 1: Athena
Share digplanet:


Applied sciences






















G. V. Prasad
జి.వి. ప్రసాద్
Residence Hyderabad, India
Nationality Indian
Ethnicity Telugu, Andhraite
Alma mater Purdue University
Illinois Institute of Technology
Alagappa College of Technology
Occupation CEO of Dr. Reddy's Laboratories
Religion Hindu
Relatives Kallam Anji Reddy (father-in-law)
Kallam Satish Reddy (brother-in-law)

G. V. Prasad (Telugu: జి.వి. ప్రసాద్) is an Indian business executive, and CEO of Dr. Reddy's Laboratories.[1][2] Prasad studied Chemical Engineering at the Alagappa College of Technology. After completing five semesters, he went on to the Illinois Institute of Technology in Chicago to complete the three remaining semesters. Prasad followed up the engineering degree with a one year MBA at Purdue University. He won the 'Outstanding Senior Student' Award from the American Institute of Chemists, Chicago chapter in 1982. He earned his Masters in Industrial Administration from Purdue University a year later. [3]

His first exposure to the world of pharmaceuticals was in 1985 with Benzex Labs, a pharmaceutical enterprise that he co-founded. Benzex was later acquired by Dr. Reddys and Prasad returned to the construction business, only to come back to pharmaceuticals in 1990 – this time as the CEO and MD of Cheminor Drugs Ltd. In 2001, Cheminor Drugs merged with Dr.Reddy's Laboratories[4] and Prasad took over as the vice-chairman and CEO of the merged entity.[5]

Early life[edit]

Prasad, the second child of Syamala and Harischandra Reddy, did his initial schooling at the Vidyaranya High School in Hyderabad, Andhra Pradesh, India. He later moved to his hometown, Nellore, where he finished his schooling at VR High School.[6]

Personal life[edit]

Prasad is married to Anuradha, the daughter of Kallam Anji Reddy, who is the founder of Dr Reddy's Labs.[7] Anuradha is the managing trustee of Dr Reddy's Foundation as well as the founder-director of Saptaparni, an organisation promoting the traditions and culture of India.[8]

Early career[edit]

After completing his Masters, Prasad returned to India and joined his father's construction business, immersing himself in various projects in Karnataka. In 1985, he co-founded Benzex Labs, an API manufacturing company, which was later acquired by Dr Reddy's. He briefly returned to the construction business before reappearing on the pharma landscape in 1990 as managing director of Cheminor Drugs Ltd. Fueled by a spirit of entrepreneurship, Prasad transformed Cheminor into a world class API and Generics manufacturer, largely through his focus on professionalism, good governance and transparency.

In 2001, Cheminor Drugs merged with Dr.Reddy's Laboratories and Prasad took over as the vice-chairman and CEO of the merged entity. Prasad is widely credited as the architect of Dr. Reddy's successful global generics strategy. He envisioned newer business platforms like the Custom Pharmaceutical business and Specialty pharmaceuticals and is dedicated to building the innovation side of the business.

Professional affiliations[edit]

  • AP State Committee, WWF-India
  • Member of the Advisory Board, Acumen Fund
  • Member of the Board, Infotech Enterprises Ltd.
  • Member of the Board, Diana Hotels, India
  • Member of the Board, Ocimum Bio Solutions
  • Member, American Chemical Society
  • Member, American Institute of Chemical Engineers
  • Served as Chairman of the CII National Committee on Environment and the Intellectual Property Committee (2006–2007)


External links[edit]

Original courtesy of Wikipedia: http://en.wikipedia.org/wiki/G._V._Prasad — Please support Wikipedia.
This page uses Creative Commons Licensed content from Wikipedia. A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia.
21708 videos foundNext > 

G.V. Prasad, Chairman, Dr. Reddy's Laboratories Ltd.

"If you look at the industry, we started with reverse engineering, the active pharmaceutical ingredient, the API or the bulk drug as it is called, this is ba...

GV Prasad on Dr Reddy's future plans

GV Prasad, chairman and CEO, Dr Reddy's Laboratories talks to Mint about his journey since he took over in April this year and future plans for the company.

AXA's GV Prasad Shares Insights on Shared Services and Outsourcing in Asia

INTERESTED IN LEARNING MORE ABOUT THIS TOPIC? http://www.ssweekasia.com/ For more information contact us at enquiry@iqpc.com.sg Phone: +65 6722 9388 SSON's D...

Mr. GV Prasad, Co-Chairman & CEO, Dr. Reddy’s Laboratories Ltd. @BioAsia

Mr. GV Prasad at BioAsia.

G V Prasad CEO Dr Reddy's Laboratories Ltd

G V Prasad CEO Dr Reddy's Laboratories Ltd.

GV Prasad, Chairman & CEO, Dr Reddy's Laboratories Ltd.

G V Prasad, Chairman & CEO, Dr Reddy's Laboratories Ltd. shares his thoughts on the India market potential, the importance of the Annual Meeting of the World...

Know more about GV Prasad, CEO of Dr Reddy's Lab

GV Prasad, co-Chairman and CEO of Dr Reddy's Lab has won India's Best CEO award in Large Companies' category.


Mr G.V. Prasad, Vice Chairman and CEO, Dr. Reddy's.

Interview with G.V. Prasad of Dr Reddy's Laboratories

G.V. Prasad of Dr Reddy's Laboratories talks about the role of the company's board and practice of evaluating independent directors.

Reddy's Lab G V Prasad Speech at BITSAA Global Meet

G V Prasad, chairman and CEO of Reddy's Laboratories, spoke at BITSAA Global Meet organised by BITS Hyderabad.

21708 videos foundNext > 

271 news items


Mon, 12 Jan 2015 03:37:30 -0800

In an interview with CNBC TV18, GV Prasad, Co-Chairman & CEO, Dr. Reddy's Laboratories, said that the currency fluctuation will impact the topline and bottomline both because the value of the sale will come down but the company has some hedges which ...


Wed, 28 Jan 2015 07:35:30 -0800

Hence, his memoirs, An Unfinished Agenda, which was released recently by his son Chairman and CEO Satish Reddy, son-in-law G V Prasad and Sun Pharmaceutical MD Dilip S Shanghvi, has generated some interest. The book is as no-nonsense and ...

Business Today

Business Today
Fri, 28 Nov 2014 08:24:21 -0800

He is just back from the Sundarbans with a host of pictures of the world's largest tidal halophytic mangrove forest, taken with his new Canon 5D Mark III camera. G.V. Prasad, Co-Chairman and CEO of the $2.2-billion Dr. Reddy's Laboratories , has been a ...
Economic Times
Tue, 23 Sep 2014 14:23:15 -0700

In an exclusive interview to ET, Chief Executive Officer G V Prasad opens up about how "jugaad" attitude caused lapses among few Indian drug makers, leading US Food & Drug Administration to impose curbs on some plants. Edited excerpts from the ...


Mon, 24 Nov 2014 11:16:54 -0800

G.V. Prasad is co-chairman and chief executive officer (CEO) of Dr Reddy's Laboratories Ltd, India's largest pharmaceutical company by turnover. The firm he heads has over 16,000 employees across the world, and manufactures 190 medications and 60 ...
The Hindu
Fri, 23 Jan 2015 16:11:05 -0800

The late Dr. K. Anji Reddy's memoir, 'An Unfinished Agenda' will inspire generations to come, work for drug discovery research and make medicines available at affordable prices, said founder & managing director of Sun Pharmaceutical Industries Limited, ...

Business Standard

Business Standard
Mon, 30 Jun 2014 07:28:06 -0700

Showing enormous conviction in what they chose to do, Dr Reddy's co-chairman and chief executive officer G V Prasad says he would prefer taking risky bets on research even while adopting a cautious approach to acquisitions. While Sun Pharma's dramatic ...

The New Indian Express

The New Indian Express
Sat, 10 Jan 2015 11:07:30 -0800

“Indian patents are low in number and very little innovation is happening,” agrees GV Prasad, co-chairman & CEO, Dr Reddy's Laboratories Ltd. “Some may have filed here for geographical advantage,” he says, adding that not all patents granted for ...

Oops, we seem to be having trouble contacting Twitter

Support Wikipedia

A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia. Please add your support for Wikipedia!

Searchlight Group

Digplanet also receives support from Searchlight Group. Visit Searchlight